2019 TAG ANNUAL REPORT PROGRESS IN THE FIGHT For Better Treatment, Prevention, A Vaccine, and a Cure for HIV, Tuberculosis, and Hepatitis C Virus BOARD PRESIDENT LETTER

June 2020

Dear Friend of TAG:

In these unprecedented times, I’m prouder than ever to share Your support with you highlights from TAG’s life-saving work. As you’ll see in this 2019 Annual Report, TAG achieved major victories in the makes us struggle to end HIV, hepatitis C virus (HCV), and tuberculosis stronger. As we confront (TB) in the U.S. and around the world. the challenges of “2020 head on—from Despite an unfavorable political climate, TAG secured historic federal funding increases for research across all three disease accelerating the end areas, for programs to address domestic HIV and opioid- of HIV, HCV, and TB to related infectious diseases including HCV, and for global TB working tirelessly for programs. TAG’s hard-hitting activism convinced the Food a better response to and Drug Administration (FDA) to hold Gilead accountable for not studying their new PrEP option in women. New York State COVID-19—we ask that and City, catalyzed by TAG and partners, are closer than ever you continue supporting to reaching ending the HIV epidemic targets. TAG launched our work, and thank you the first-ever HCV diagnostics literacy program for community on behalf of everyone advocates. TAG’s TB project’s years of advocacy for research funding led to a landmark $900 million in annual global TB here at TAG. research investments.

Your support makes us stronger. As we confront the challenges of 2020 head on—from accelerating the end of HIV, HCV, and TB to working tirelessly for a better response to COVID-19—we ask that you continue supporting our work, and thank you on behalf of everyone here at TAG.

Be safe, stay well, and thank you!

Yours in the struggle,

Barbara Hughes President, Board of Directors

2 • 2019 TAG ANNUAL REPORT 2019 RESEARCH IN ACTION AWARDS

TAG’s 2019 Research in Action Awards took place on November 14, 2019, at Town Stages in New York City. TOur distinguished honorees this year were: David France, Oscar-nominated filmmaker,New York Times best- selling author, award-winning investigative journalist, and director of How to Survive a Plague and The Death and Life of Marsha P. Johnson; Matthew Lopez, Olivier Award-winning playwright/screenwriter and author of the play, The Inheritance; Amanda Lugg, long-time activist and Director of Advocacy and LGBT Programming at African Services Committee; and Dr. John ‘Jack’ Steever, Assistant Professor of Pediatrics, The Mount Sinai Adolescent Health Center, Mount Sinai Medical Center, specializing in HIV prevention and treatment in young LGBTQ people. Tom Kirdahy, Broadway producer, attorney, and human rights advocate was our honorary event chair. All photos by Alan Barnett Photography.

Two of our generous creators of previous Limited Art Editions Carrie Yamaoka, 2007’s 25/Blues, and Erica Baum, 2017’s Peer.

Honoree Matthew Lopez with honorary event chair, Broadway Producer and activist Tom Kirdahy.

(center) Honoree Amanda Lugg, doing what she does best: inspiring the masses.

Honoree Dr. Jack Steever addresses RIAA participants after accepting his award.

Three of TAG’s wonderful board members (from left to right): Honoree David France with RIAA 2019 co-host Ron Kevin Goetz; Joy Episalla (who manages our Limited Art Goldberg. Editions); and board president, Barbara Hughes.

2019 TAG ANNUAL REPORT • 3 TAG ANNUAL REPORT PROJECT UPDATES

TAG pushed the U.S. Food and Drug Administration HIV PROJECT (FDA) to hold a public hearing on Gilead’s application for approval of their new PrEP option to review lack of inclusion of key populations in research, lack of transparency, and the need for a clear generic In 2019, TAG advanced our life-saving work of pathway. Our testimony and that of partners led to the ensuring progress on research toward improved HIV FDA requiring further research in individuals at risk for prevention and a cure, and accelerating the end of HIV vaginal exposure to HIV, including cisgender women as an epidemic. At the start of the year, the President and transgender men. announced the Ending the HIV Epidemic initiative to first stop new transmissions in 57 jurisdictions, and Furthering community-inclusive research, TAG eventually bring the whole nation below epidemic levels launched a survey on community perspectives on by 2030. This initiative presents a huge opportunity, the future of HIV prevention trials. We led an analysis while highlighting several crucial gaps. TAG supported of HIV cure-related clinical trials in 2019, publishing the ACT NOW: END AIDS Coalition, of which we are a findings that highlight important issues, such as co-founder, in delineating core community principles the continuing underrepresentation of women in needed to actually end the epidemic for everyone in cure research. TAG’s Cure Research Media Monitor the U.S. These core principles are especially important tracked progress on HIV cure research and debunked for vulnerable populations who are threatened by other myths, and our first-everPipeline Report on sexually administration policies. To ensure that jurisdictional transmitted infections analyzed prospects and needs plans to end the epidemic reflect community priorities, for improving prevention and treatment for gonorrhea, we took the lead in launching a new ACT NOW: chlamydia, and syphilis. END AIDS Coalition initiative to support community organizations representing some of the hardest hit TAG’s 2019 HIV Publications communities to participate in their local Ending the • Gene Editing in HIV Research HIV Epidemic planning. In New York, we continued to advance the end of the HIV epidemic, celebrating • A Landscape Analysis of HIV Cure-Related progress—including a 28% drop in new diagnoses Clinical Trials in 2018 in New York State between 2014 and 2018—while • Pipeline for Gonorrhea, Chlamydia, and Syphilis also calling attention to key unmet needs, including • Antiretroviral Therapy Pipeline accessible prevention and testing for young people of color and transgender communities. • HIV Vaccines, Passive Immunization, and Antibody Gene Transfer Pipeline We fought back against unfair pricing and access • Research Toward a Cure and Immune-Based policies that threaten the ability to end HIV. As you’ll Therapies Pipeline read more about in our Policy update, we submitted • From Engagement to Leadership: Placing testimony to Congress on the need to reduce the high Community Priorities at the Heart of HIV price of pre-exposure prophylaxis (PrEP). We pushed Prevention Research (TAGline May 2019) back against the U.S. government’s plan to pay Gilead millions of dollars to distribute its own product as part • Scientific Complexity and Ethical Uncertainties: of the Ready, Set, PrEP program, and supported a The Importance of Community Engagement in rejection of Gilead’s claims over PrEP patents resulting HIV Cure Research (TAGline May 2019) from government-funded research. TAG led a group • Dispatches from the War on Science (TAGline of eight HIV research and advocacy groups in filing November 2019) a friend-of-the-court brief in support of the plaintiffs in Staley v. Gilead, who filed suit against four drug • Centering Intersectional Movement Building companies for price-fixing and keeping generic drugs in 2020 Election HIV Advocacy: Guidance from off the market. Movement Leaders (TAGline November 2019)

4 • 2019 TAG ANNUAL REPORT TAG PROJECT UPDATES

building awareness in the White House Office of POLICY PROJECT Management and Budget, the State Department, and the Department of Health and Human Services, and cultivating buy-in from key federal agencies involved in TB research to hit the U.S. target. TAG’s policy team achieved historic wins in 2019 towards ending HIV, tuberculosis (TB), and hepatitis Back in New York, TAG advanced the end of HCV C virus (HCV). In the final budget passed by Congress in the state by working with the Surveillance, and signed by the President in December 2019, Data, and Metrics working group of the New York TAG and our partners secured FY20 federal funding State HCV Elimination Task Force to generate increases for global TB programs and research ($8 recommendations for the governor, and serving on million increase), HIV research ($25 million increase), the Elimination Metrics Advisory Committee to guide opioid-related infectious disease lines ($5 million the development and monitoring of HCV elimination increase), HCV vaccine research ($8 million), and new metrics and progress. In parallel, we initiated a initiatives under the administration’s Ending the HIV community engagement and advocacy initiative Epidemic goals ($140 million increase). toward viral hepatitis elimination in New York City, We influenced policy and legislation to improve access coordinating a series of borough events. TAG helped to medicines. Our input to Speaker Pelosi’s office build a citywide coalition in response to deep cuts strengthened and broadened drug pricing reforms under Article 6 State matching funds to New York City in the Elijah E. Cummings Lower Drug Costs Now health programs. This emerging coalition successfully Act, which the House passed. TAG was specifically restored $65 million through reallocation of New York called upon by the House Committee on Oversight City general funds. and Reform to submit testimony for a Congressional hearing investigating Gilead’s high pricing of Truvada We also welcomed the newest junior member of our for PrEP. Preparing for the 2020 election cycle within policy team, Saurav Madoori, baby of proud parents parameters permissible for 501(c)3 organizations, TAG Suraj Madoori (TAG’s Director of U.S. & Global Health and the ACT NOW: END AIDS Coalition engaged Policy) and Shivani Thaker. with 2020 presidential candidate campaign offices about their platforms and policy plans to end the HIV TAG’s 2019 Policy Publications epidemic. • Closing the Gap in Tuberculosis Research and To advance efforts to end TB, TAG co-organized Development Funding Briefs (for Legislative & a Congressional briefing and a series of advocacy Executive Agencies) trainings to build capacity for legislative campaigns. • Act Up. Fight Back. Fight TB: Potential Pathways These collaborative efforts resulted in new bipartisan to R&D Funding Advocacy for the U.S. TB Congressional endorsements for the Comprehensive Community (TAGline May 2019) TB Elimination Act (which includes provisions for research as well as domestic TB programs), and the • Regime Change in America: Tracking TAG’s introduction of the End TB Now Act (which supports Work Across Eight National Election Cycles global TB programming and research). Under a (TAGline November 2019) new partnership with the National TB Controllers • Centering Intersectional Movement Building Association, TAG continued to support a cutting-edge in 2020 Election HIV Advocacy: Guidance from TB response in New York, and launched community Movement Leaders (TAGline November 2019) engagement initiatives in Indiana, Los Angeles County, and Louisiana to support those and other jurisdictions’ • This Is Not a Drill: Science, Solidarity and the efforts to end TB. Policy staff advanced the concept 2020 Elections (TAGline November 2019) of “fair share” funding targets for TB research,

2019 TAG ANNUAL REPORT • 5 TAG PROJECT UPDATES

capacity building materials. We expanded our crowd- HCV PROJECT sourced data platform, mapCrowd, to include country- specific information on the latest generic hepatitis C medications and diagnostics. We partnered with Harm Reduction International to integrate data on TAG’s groundbreaking HCV community engagement harm reduction coverage, treatment restrictions, and advocacy initiatives in 2019 achieved notable and inclusion of people who use drugs in national global policy wins. Our actions helped ensure that strategies. Our collaboration enabled analysis of outcome documents from the United Nations High- new data from high-burden countries, including Level Meeting on Universal Health Coverage included Iran, Nigeria, the Philippines, and Uzbekistan. TAG, addressing viral hepatitis. TAG provided vital feedback the global hepCoalition network (of which we are to raise the importance of hepatitis C activities and a co-founder), and partners launched hard-hitting to promote campaigns and fact sheets in multiple languages Furthering our harm to assist communities and inform policymakers technical reduction on progress made towards HCV elimination. The in the U.S. community checklist, Who Counts in Our National support for advocates President’s Hepatitis Plans?, the Comprehensive HCV Package around the world, Emergency of Services for People Who Use and Inject Drugs TAG disseminated Plan For infographic, and Have A Heart, Save My Liver! “ AIDS Relief diagnostics brief have been used by partners to inform critical information (PEPFAR) community trainings and high-level policy meetings and capacity guidance to in Georgia, India, Malaysia, Lao People’s Democratic building materials. countries. Republic, South Africa, and Tanzania. This feedback resulted in tripling the number of mentions for viral TAG spearheaded another campaign, challenging hepatitis in the final PEPFAR guidance released in human rights abuses and calling for the release of 2020, which could provide opportunities to integrate three detained HIV/HCV lawyers and activists in hepatitis in country programs. Changsha, China. This campaign raised awareness among over 15,000 people on social media. TAG In partnership with the Foundation for Innovative New campaigned to increase programming and funding for Diagnostics (FIND), our HCV Project launched an in- people with HIV/HCV coinfection through the Global depth diagnostics literacy program for 75 advocates Fund to Fight AIDS, Tuberculosis, and Malaria, and in the countries of Georgia and Malaysia—the continues to advocate for expanded access to generic first, to our knowledge. Partnering with FIND, the hepatitis C medications by AbbVie, Gilead, and Georgian Harm Reduction Network, and the Georgian licensed generic manufacturers. Community Advisory Board, TAG provided technical capacity building among community leaders and harm TAG’s 2019 HCV Publications reductionists. Monitoring policy changes continues • New HCV Fact Sheets for sofosbuvir/daclatasvir through a newly formed, community-led steering and Mavyret (glecaprevir/pibrentasvir) committee and stronger relationships with the Georgian Ministry of Health. Advocacy workshops with the Positive • Activist Guide to Hepatitis C Virus Diagnostics Malaysian Treatment Access and Advocacy Group, and training curriculum slide deck medical providers, and grassroots leaders from drug user, • HCV Diagnostics Pipeline LGBTQ+, and sex worker activist communities, helped • HCV Treatment Pipeline make community engagement and decentralized testing integral components in Malaysia’s elimination strategy. • Love Trumps Hate: Building People Power and Reshaping Political Struggles Toward Harm Furthering our technical support for advocates around Reduction, Humanity, and Hope (TAGline the world, TAG disseminated critical information and November 2019)

6 • 2019 TAG ANNUAL REPORT TAG PROJECT UPDATES

To facilitate uptake of evidence-based interventions to TB PROJECT end TB, TAG’s TB project advanced several campaigns to increase access to essential TB medicines (bedaquiline, pretomanid, delamanid, and rifapentine) and diagnostics (GeneXpert). These campaigns TAG’s TB project achieved several victories for TB centered on technologies developed with public and research and access in 2019. Our decades of TB philanthropic funding, but manufactured and sold by research funding advocacy have been bearing fruit— companies at unaffordable prices. our signature report showed that global funding for TB research and development reached a new all-time Through all this work and more, our TB project high in 2018 of over $900 million. The World Health engaged and empowered community advocates. Organization (WHO) incorporated TAG-developed Our advocacy workshops on preventive therapy and targets for country funding into their Global Strategy pediatric TB supported activists in over 15 countries to for TB Research and Development, and the U.S. call for access to preventive therapy and pediatric TB government announced meeting its TAG-set target. interventions. We held the Our advocacy TAG’s research advocacy, community engagement first cross- efforts, and participation in trial design also training to ensure that contributed to the launch of important studies between advances of science and the defense of rigorous TB science. A much- TB activists translate into sound anticipated trial from the National Institute of Allergy (represented policy similarly and Infectious Diseases AIDS Clinical Trials Group to chiefly by the “ test a newer drug’s ability to prevent drug-resistant TAG-supported achieved success. TB started. TAG testified before the FDA regarding Global TB pretomanid, a new TB drug, to express concern Community Advisory Board) and access to medicines regarding remaining research questions, and the activists, to foster common understanding, solidarity, importance of upholding stringent evidentiary and stronger campaigns to improve access to TB standards for new TB medicines. The TAG-coordinated commodities. Community Research Advisors Group (the community advisory board to the Centers for Disease Control and TAG’s 2019 TB Publications Prevention’s Tuberculosis Trials Consortium) proposed • TB LAM Testing Briefs a qualitative study of barriers and facilitators to • An Activist’s Guide to Rifapentine for the enrolling adolescents in TB treatment trials; this study Treatment of TB Infection also began in 2019. • 2019 Report on TB Research Funding Trends Our advocacy to ensure that advances of science • National TB Checklist Update translate into sound policy similarly achieved success. • TB Activist Toolkits Update TAG and partners’ advocacy for WHO guideline • Pediatric Tuberculosis Diagnosis, Treatment, and changes and participation in guidance development Prevention Pipeline secured life-saving updates. WHO guidance now • TB Diagnostics Pipeline strongly recommends molecular diagnosis for • TB Treatment Pipeline TB for all, and less toxic, more effective, all-oral • TB Vaccines Pipeline regimens for treating drug-resistant TB. As with our HCV project, our TB project successfully influenced • Sound Off: Three Activists Reflect on Community PEPFAR’s guidance to countries to promote better TB Victories and Priorities in TB Research (TAGline diagnostics and treatments in global AIDS programs, May 2019) including TB preventive therapy, pediatric TB • The Final Frontier: Breaking Down Barriers interventions, and molecular and rapid TB tests. to Community Engagement in Diagnostics Research (TAGline May 2019)

2019 TAG ANNUAL REPORT • 7 2019 TAG FINANCIALS

Balance Sheet

Assets 2019 2018 Cash and cash equivalents $1,610,906 $1,534,231 Unconditional Promises to Give 496,981 1,216,871 Accounts receivable 7,583 1,139 Prepaid expenses and other current assets 37,208 31,594 Donated artwork 492,739 439,739 Security deposit 72,463 72,463 Property and equipment - net 18,580 26,728 Total Assets $2,736,460 $3,322,765

Liabilities and Net Assets Liabilities Accounts payable and accrued expenses $38,603 $25,396 Deferred rent 33,362 42,520 Total Liabilities 71,965 67,916 Net Assets Without donor restrictions 1,537,543 1,736,034 With donor restrictions 1,126,952 1,518,815 Total Net Assets 2,664,495 3,254,849 Total Liabilities and Net Assets $2,736,460 $3,322,765

Statement of Cash Flows 2019 2018 Cash Flows from Operating Activities Increase (decrease) in net assets ($590,354) ($701,749) Adjustments to reconcile increase (decrease) in net assets to net cash used by operating activities: Depreciation 9,547 10,873 (Increase) decrease in: Unconditional promises to give 719,890 333,023 Accounts receivable (6,444) (1,139) Prepaid expenses and other assets (5,614) (6,210) Donated artwork (53,000) (25,239) Increase (decrease) in: Accounts payable and accrued expenses 13,207 (264) Deferred rent (9,158) (12,549) Net Cash Used by Operating Activities 78,074 (403,254)

Cash Flows from Investing Activities Acquisition of property and equipment (1,399) (11,627) Proceeds from sales of fixed assets - - Net Cash Used by Investing Activities (1,399) (11,627) Net decrease in cash and cash equivalents 76,675 (414,881) Cash and cash equivalents, beginning of year 1,534,231 1,949,112 Cash and Cash Equivalents, End of Year $1,610,906 $1,534,231

8 • 2019 TAG ANNUAL REPORT Statement of Activities 2019 Without Donor With Donor Restrictions Restrictions Total Revenue and Other Support Contributions $277,143 $1,484,565 $1,761,708 Fundraising benefit events 287,848 - 287,848 Less: Direct benefit expenses (79,422) - (79,422) Donated artwork, goods and services 174,796 - 174,796 Art sales, net of cost of goods sold 500 - 500 Other income 27,413 - 27,413 Interest income 1,347 - 1,347 Net assets released from restrictions 1,876,428 (1,876,428) -

Total Revenue and Other Support 2,566,053 (391,863) 2,174,190

Expenses Program Services HIV Program 590,447 - 590,447 Hepatitis C Virus Program 307,575 - 307,575 TB/HIV Program 1,246,647 - 1,246,647 Total Program Services 2,144,669 - 2,144,669

Supporting Services Management and general 379,723 - 379,723 Fundraising 240,152 - 240,152 Total Expenses 2,764,544 - 2,764,544

Increase (decrease) in net assets (198,491) (391,863) (590,354) Net assets, beginning of year 1,736,034 1,518,815 3,254,849 Net Assets, End of Year $1,537,543 $1,126,952 $2,664,495

Summary of 2019 FunctionalSummary Expenses of 2019 Functional Expenses

Management & Administration 14% Fundraising 9%

Program Services 77%

2019 TAG ANNUAL REPORT • 9 2019 TAG CONTRIBUTORS

$100,000 or more $5,000 to $9,999 Ivy Kwan Arce in memory Fung Chun Bong The Aurum Institute The Calamus Foundation of Sally C. Cooper, Karina Jennifer J. Furin, MD, PhD Bill and Melinda Gates JPMorgan Chase Foundation Haslip, and Michael Callen Robert Gillard and James Foundation in recognition of TAG Board Dr. J. Michael McCune III Harrington in honor of ViiV Healthcare member Richard Lynn and Dr. Karen Kaye Smith- Monte Steinman Celeste B. Cooper McCune David Gold Eddie Pelto in memory of $50,000 to $99,999 David Corkery David Greenblatt Daniel A. Volpe, Jr. Broadway Cares / Equity The Gendal Family Mark Harrington Bruce Schackman and Ed Fights AIDS Foundation in honor of Christina and Kenneth Hecht Sikov Foundation for Innovative Monte Steinman in memory of Richard Jeff Schoenfeld and Matt New Diagnostics Richie Jackson and Jordan Harrington Holbein Elizabeth Glaser Pediatric Roth Hon. James C. Hormel Bill Shea and Frank Selvaggi AIDS Foundation Janssen Therapeutics Housing Works / Charles King The Sigal Family Foundation: Global Drug Facility via Stop Jameel Jiwani IAVI / Dr. Mark Feinberg, CEO David Sigal and New York TB Partnership Robert W. Lennon and Mark Tom Kirdahy and the late State Senator Brad Hoylman Stop TB Partnership hosted Gilrain Terrence McNally in Mrinal Vikram and Kevin by UNOPS Richard M. Lynn and Joseph memory of Gary Bonasorte Finnegan Joy A. Tomchin Evall Emmy Kondo and Danny John Voelcker Veterans Affairs Medical Médecins du Monde Rosenthal Weil, Gotshal & Manges LLP Center of Washington, DC Robert Monteleone Jay Leitz The Andrew D. Zacks Laura A. Morrison Michael K. Longacre in Foundation $25,000 to $49,999 National Coalition of STD memory of Tony Ortiz The Debs Foundation: Richard Directors Alby P. Maccarone, Jr. $1,000 to $2,499 A. and Barbara Knowles National TB Controllers Loring McAlpin Amida Care / Doug Wirth Debs; Nick Debs Association Albert S. Messina and Hauser & Wirth Marc Wolinsky and Barry C. Katherine C. and Thomas M. Kenneth L. Jennings in Ash III in memory of Richard Fred Hutchinson Cancer Skovgaard honor of our friend Richard Harrington Research Center Jacobs AVAC / Mitchell Warren M•A•C AIDS Fund $2,500 to $4,999 George J. and Mirla N. Jack M. Battaglia Merck & Co. 1199 SEIU Morrison Erica Baum Abbott Laboratories Craig Murray in honor of Kevin Michael Bennett in memory of and Neil Goetz $10,000 to $24,999 Jim Aquino Ty French Otsuka Novel Products GmbH amfAR, The Foundation for Jeff D. and Michelle Kleinert Karen Bronzo and Jefferson AIDS Research Bader Marvel S. Platoff Foundation Rabb Michael Becker and Tee Bob Bronzo Kevin Ryan Brooklyn Community Scatuorchio Dr. Joseph Burzynski Andrew C. Schirrmeister III in Foundation honor of Monte Steinman Annie Bennett Glenn Fund in Cristopher Canizares Steven F. Capone Evan Schwartz and Robert honor of P. Forrest Williams, Benson Cohen Jr. Lawrence Corey, MD Fitterman John F. Duane and Mary E. Jonathan Creighton and H.A. ‘Hal’ Sedgwick in honor Kevin and Neil Goetz / Screen Northridge Engine/ASI Megan Harrington of Cassandra Leveille Marc E. Elovitz in honor of The Great American Michael Cunningham and Ken Kurt R. Soderlund Richard Lynn and Joseph Corbett Songbook Foundation Evall Rachel B. Tiven and Seth M. Dick Dadey Marnin The Hepatitis C Mentor and David France Support Group Arianne Z. Dar / New Ground W. Kirk Wallace and Mark M. Suzanne Gay and Bryn M. Gay Marta Heflin Foundation Fund of Marin Community Sexton in memory of Phillips G. Foundation Bobby McLain and Alberto Gay, Jr. Thomas P. Wilczak and Steven Hon. Thomas K. Duane R. Quinkert Blanquel Judith and Richard Harrington Kimberly Elliott in honor of Nadine Witkin Paula Hartstein Jane Silver Barbara F. Hughes Ruth Finkelstein and BC Craig Noel E.D. Kirnon and Michael Bruce C. Francis in memory of D. Paley Rich DeNagel

10 • 2019 TAG ANNUAL REPORT $500 to $999 Jeff Mendoza and Dr. Chuck $250 to $499 Linda Liedtka AIDS Action Baltimore Sklar Michele Araujo Mayo Schreiber Association of State and Sally Morrison in honor of Dr. Joe Baker in honor of Tom Merle C. McCann MD in Territorial Health Officials Lucy Painter Kirdahy, for the Opening of memory of John Stuban Robert J. and Margot Bazell Mount Sinai Institute for “The Inheritance” Fernando J. Alva Miras Michael Beltran and Timothy Advanced Medicine Alvin Baum in memory of Joseph S. Monteleone Ford John Nesbit and Cristina Richard Harrington of San Fraser D. ‘Skip’ Mooney Corbin Francisco, father of Mark Peter F. Brown and Dr. Dr. Steven S. Muchnick and Harrington Margaret Hamburg Kim Nichols in honor of Eric Milliren Amanda Lugg Robert Beatty in honor of Steven J. and Denise Chickery Scott Newman Natalie Olstein in memory of Monte Steinman Michael Coady Ann Northrop Bobby Rosenthal, to honor Danielle Berz in honor of Robert N. Croonquist Kathleen O’Leary in honor of his mother Suzanne Benzer Jameel Jiwani Alan Cumming and Grant Bob Bronzo on her 80th birthday; a gift Jessica Boyle Shaffer Stephanie Oster from her friends Richard Cardillo in memory of Paul L. Dietz Pam Parker Jason Osher and Richard Peter F. Diffly, Jr. Eric Eidelman and Julie A. Laura Pinsky in memory of Schubel Dr. Charles C.J. Carpenter and Mirolla Rich DeNagel Daniel Ptacek Mrs. Sally F. Carpenter Stephen A. Foster Sheila Reeves Robert H. Remien Patricia Costello in memory of Steven M. Frank and Dr. Walter Rieman in memory of Jim Konetsky Clifford Richner Elizabeth S. Powell Tom Stoddard Scott Dainton Erica Rosengart New York State Assembly Roche / Robin Thomas Judith Davis-Fagan Kimberleigh Smith in honor of Member Deborah J. Glick Amanda Lugg Jamie Saakvitne and Daniel Lynda Dee, Esq. GMHC / Kelsey Louie Robin Thomas Chow in honor of Dr. John Peter Morris Dixon God’s Love We Deliver B. Steever Oliver R. Tobin Jim Eigo Roy M. ‘Trip’ Gulick, MD Greig Sargeant Barbara Toll in honor of Jeff Jennifer Eisenstadt in honor of Health GAP Mendoza Lyle Saunders in honor of Dr. John Steever Alex Henderson and Oskar Laura Morrison Christian Urrutia Paula Elbrit in honor of Dr. Moguel Peter A. Schamel John B. Steever Robert C. Henry plus donations from an Sarah F. and Roy E. Monica Gerber Drew Hodges and Peter Schutzengel in memory of additional 195 generous Leslie Asako Gladsjo Kukielski Hartly Fleischmann contributors, including Ron Goldberg Anonymous gifts Tim Hosking and Audrey Stephan Shaw and Sunita Sokoloff in honor of Rich Viswanath Joy Harris We would also like to thank Lynn for his many and Drew Hodges in honor of Tom David R. Shaw and Francesca those who gave generously Kirdahy, for the Opening of continuing efforts on behalf Zaccheo to TAG as part of campaigns “The Inheritance” of TAG Andrew Shih hosted via Act Blue Charities, Kevin Jennings and Jeff Davis PayPal Charitable Giving (for Michael T. Isbell in memory of Virginia Shubert and David Spencer Cox in honor of David France Board member Jim Aquino’s Sipress participation in the Boston Jay Johnson and Thomas Richard Jefferys in memory of Jane Silver Marathon), and Network for Richard Harrington Cashin Peter Staley Good (Board member Eddie Presston Kennedy in honor of Hooman Kamel in honor of Pelto’s FaceBook campaign). Monte Steinman those who have passed and the PrEP4All Collaboration TAG was the beneficiary of those still fighting Marc Szafran Geremy Kawaller funds raised as part of the 2019 NYC AIDS Walk, and Paul Kennedy Cathy E. Taub and Lowell C. Sung Woon Kil in honor of Freiberg through participation in the Babette Krolik and Sara Rafsky Bob Bronzo Amazon Smile program. Keith S. Tobin, MD Burt R. Lazarin James Krellenstein TAG would like to thank Dennis Trunfio Justin D. Lee and Michael E. Joseph Lauretano artist Glenn Ligon, Print Positive NY, SpotCo, and Gunther Paolo Danilo Vicino Charles S. Laven Board members Kevin Goetz Lisa Volling in honor of Jameel David C. Levine Susan Leimsider in honor of and Jeff Mendoza for their Jiwani Joseph McConnell and Erik Erica Lessem generous in-kind donation Haagensen P. Forrest Williams, Jr. Claire Lennon of goods and services, to support fundraising events Margaret Lennon that benefitted TAG.

2019 TAG ANNUAL REPORT • 11 About TAG Thank You, Board Members 2020 BOARD OF DIRECTORS Treatment Action Group (TAG) The Board and Staff of Treatment PRESIDENT: Barbara Hughes is an independent, activist and Action Group thanks Bobby VICE PRESIDENT: Robert W. Lennon community-based research and McLain, Jeff Mendoza, and policy think tank fighting for better Monte Steinman for their years of SECRETARY/TREASURER: Laura Morrison treatment, prevention, a vaccine, dedicated and significant service and a cure for HIV, tuberculosis, and on TAG’s Board of Directors. Jim Aquino Frank Bua hepatitis C virus. Dick Dadey TAG works to ensure that all TAG Limited Art Editions Nick Debs Joy Episalla people with HIV, TB, or HCV receive Each year at its Research in Action Kevin Goetz lifesaving treatment, care, and Awards, TAG presents a new, Roy Gulick, M.D. information. limited edition work of art. Past Jameel Jiwani artists include Glenn Ligon, Zoe Richard Lynn, Ph.D., M.P.H. We’re science-based treatment Leonard, Erica Baum, Rosalind Robert Monteleone activists working to expand and Fox Solomon, Joy Episalla, Kate Eddie Pelto accelerate vital research and David Sigal Shepherd, Nan Goldin, Robert effective community engagement Mrinal Vikram Gober, Bill Jacobson, fierce pussy, with research and policy institutions. Donald Moffett, Tony Feher, Carrie 2020 STAFF Yamaoka, David Armstrong, and TAG catalyzes open collective EXECUTIVE DIRECTOR: action by all affected communities, Richard Renaldi. Mark Harrington scientists, and policy makers to end DEPUTY EXECUTIVE DIRECTOR: HIV, TB, and HCV. TAG retains an inventory of many of Erica Lessem the editions for sale to the public, TB PROJECT OFFICER: Support TAG and all proceeds benefit TAG’s work. David Branigan If you’re interested in purchasing In 2019, TAG made many strides TB PROJECT CO-DIRECTOR: an edition or learning more about against HIV, HCV, and TB. In 2020, Mike Frick the available editions, detailed we continue our vital core work STATE AND LOCAL POLICY DIRECTOR: information can be found at to end HIV, HCV, and TB, while Annette Gaudino http://www.treatmentactiongroup. applying our expertise to the org/limited-art-editions. HCV PROJECT DIRECTOR: COVID-19 pandemic. A robust Bryn Gay response based on science and FINANCE MANAGER: driven by community priorities is Christopher George more crucial than ever. DIRECTOR OF FINANCE AND OPERATIONS: Make a gift to TAG and help us Sabrina Guerrero-Morris advocate for the needs of all BASIC SCIENCE, VACCINES, AND people affected by HIV, HCV, TB, CURE PROJECT DIRECTOR: and COVID-19. Richard Jefferys Support TAG today: www. HIV PROJECT DIRECTOR: treatmentactiongroup.org/support. Jeremiah Johnson GRANT OFFICER: Does your organization have a Jason Kirk matching gifts program? Don’t GOVERNMENT RELATIONS AND miss your chance to make a gift POLICY OFFICER: that keeps on giving. Complete Elizabeth Lovinger and send us your company’s U.S. AND GLOBAL HEALTH POLICY matching gift form to double your Glenn Ligon Black Rage (back cover), DIRECTOR: Suraj Madoori contribution’s impact! 2019 ADMINISTRATOR: Joseph McConnell TB PROJECT CO-DIRECTOR: Lindsay McKenna COMMUNICATIONS MANAGER: Dorrit Walsh

12 • 2019 TAG ANNUAL REPORT www.treatmentactiongroup.org

90 Broad Street, Suite 2503 New York, NY 10004 Tel 212.253.7922

[email protected]

TAG is a nonprofit, tax-exempt 501(c)(3) organization. EIN 13-3624785